EMA — authorised 27 November 2015
- Marketing authorisation holder: Horizon Pharma Ireland Limited
- Status: approved
EMA authorised Ravicti on 27 November 2015
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 27 November 2015.
Horizon Pharma Ireland Limited holds the EU marketing authorisation.